|| List of recent Probiotic-related patents
| Probiotics with enhanced survival properties|
The present invention relates to a method for screening for a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. The present invention further relates to a method for screening for culture conditions that provide a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract.
An ingestible composition including a probiotic contained in a mixture of a phospholipid and a glyceride, useful for nutrition of infants and children.. .
An ingestible composition including a probiotic contained in a mixture of hydrolyzed protein, a first carbohydrate, a second carbohydrate and optionally a compound binder and/or a lipid component, useful for nutrition of infants and children.. .
|Probiotic bacterial strains and symbiotic composition containing the same intended for infant food|
Selection of probiotic strains belonging to the genus bifidobacterium and to a symbiotic composition containing the same for use of feeding infants, is described.. .
|Probiotic enriched and low organic acid food products|
This invention relates to a fruit-based food product such as beverages or fruit purees, comprising a concentration of live and stable probiotics, which is preferably greater than 108 cfu/ml, a high fruit content, which is preferably greater than 50%, and a low organic acid content, and wherein the production of off-tastes is reduced or diminished in relation to the initial fruit matrix, as well as method for preparing a food product such as this.. .
|Rywhe / the drink of life|
Rywhe is a natural, raw, organic beverage. Rywhe contains 13 vitamins, the 7 major minerals, 13 trace minerals, plant proteins, fiber, 17 amino acids, healthy probiotics, living enzymes, antioxidants, flavonoids, and phytonutrients.
|Probiotic compositions and methods for the treatment of obesity and obesity-related conditions|
The present invention provides a method and composition for ameliorating or reducing the symptoms and signs and for the treatment of obesity, diabetes, and related conditions in a mammal in need thereof, said method comprising administering effective amounts of a pharmaceutically acceptable composition comprising a mixture of probiotic microorganisms with distinct but complementary pathways of carbohydrate metabolism, for a time sufficient to ameliorate, reduce or treat at least one sign or symptom of obesity, diabetes or cardiovascular disease. Compositions having the desired properties, and methods for their use in pharmaceutical and nutritional formulations, are provided..
|Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme|
This invention relates to polybacterial probiotic preparation, which includes new strains of lactic acid bacteria lactobacillus gasseri 7/12 nbimcc no. 8720, lactobacillus plantarum f12 nbimcc no 8722 and lactobacillus helveticus a1, nbimcc no 8721 and has the following set of properties: antioxidant, hypocholesterolemic effect, anti-inflammatory immunomodulating effect, ability to release bioactive peptides that inhibit angiotensin-converting enzyme (ace), which is responsible for the high blood pressure.
|Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity|
A composition comprising probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity is described. The composition is capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity and minimizes the secondary effects due to said pharmacological treatment..
|Probiotic functional food suitable for immunocompromised individuals undergoing treatment such as chemotherapy and/or radiotherapy|
The invention relates to a probiotic functional food comprising: a biomass of lactobacillus spp. Strains conditioned to withstand temperatures of between −30 and −40° c., and cryoprotective agents.
|Protein stabilized probiotics and personal care products|
The present invention also relates to the personal care product being a feminine care product particularly aimed at female urogenital health to treat or prevent vaginal infections. Oral and sinus infections, however, may also be benefited by the composition..
|Probiotic bacteria for the topical treatment of skin disorders|
The present invention relates to a probiotic bacteria, and/or soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria for use in the treatment of a disorder associated with tight junction function, characterised in that the probiotic bacteria, soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria is formulated for topical administration.. .
|Probiotic bacteria having antioxidant activity and use thereof|
The present invention relates to a composition having antioxidant activity. Furthermore, the present invention relates to probiotic bacteria having antioxidant activity and the use thereof..
|Bifidobacterium bifidum strains for application in gastrointestinal diseases|
The present invention provides a strain of bifidobacterium bifidum or mutant or variant thereof showing at least an adhesion of about 10 bacterial cells per mm2 of epithelial cell monolayer or having at least an adhesion index of 1.5 and a strain of bifidobacterium bifidum or mutant or variant thereof being bifidobacterium bifidum mimbb75, deposited under deposit no. Dsm 24514, or a mutant or variant thereof for use as probiotic, in foodstuff and/or as a medicament.
|Cold infusion process for fortifying corn and/or soybeans|
This invention relates to a cold infusion process for fortifying corn and/or soybeans with one or more vitamin, non-vitamin, mineral, non-mineral, botanical, hormone, herb, neutraceutical, lipid, carbohydrate, amino acid, acid, salt, prebiotic, or probiotic functional additives. This invention also discloses an infused corn and/or soybean produced by the process of infusing the corn and/or soybean at a temperature of less than about 120° f.
|Materials and methods for treating conditions associated with pathogenic biofilm|
The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin d3..
|Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny|
The present invention provides a probiotic, lactobacillus paracasei ncc 2461, i.e. St11, for use by administration to expectant females and/or lactating mothers, and to their progeny for the reduction or prevention of the development of allergic immune responses in progeny.
|Nutritional compositions including branched chain fatty acids for improving gut barrier function|
Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. Such medical conditions include infection, sepsis, malabsorption, allergy, inflammatory bowel disease, and diarrhea among others.
|Nutritional compositions including branched chain fatty acids and methods of using same|
Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include allergies, autoimmune diseases, among others.
|Nutritional compositions including branched chain fatty acids for wound healing|
Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include wounds, mucositis among others.
|Use of patchouli alcohol in preparation of drug against helicobacter pylori|
The present invention relates to a use of patchouli alcohol in the preparation of a drug against helicobacter pylori. The drug according to the present invention is composed of the patchouli alcohol and pharmaceutically acceptable additives, wherein the content of the patchouli alcohol is 0.5-70%.
|Gluten-free ready-to-eat food composition|
A gluten free, ready-to-eat food product is provided comprising millet and a flavoring. In some embodiments, the gluten-free food product may also be dairy-free and/or allergen free.
|Protection of microbial cells from acidic degradation|
A simple cellulose sulphate based microencapsulation technology has been applied to encapsulate bacterial or other microbial cells, which produce and release digestive enzymes and thereby provides an acid resistant shelter for these microbial cells. Surprisingly, the resulting spheres were found to provide sufficient protection for encapsulated cells from treatment with aqueous acidic solutions.
Disclosed herein are probiotic compositions comprising a mixture of at least two probiotic bacteria, including streptococcus salivarius k12® (blis k12®) and at least a lactobacillus bacteria. The streptococcus salivarius k12® (blis k12®) may comprise streptococcus salivarius k12® (blis k12®) baa1024.
|Method for producing probiotically derived compounds|
A method for producing naturally derived beneficial compounds including dispersing a microbiological culture media including at least one live probiotic organism, and at least one nutraceutical and/or at least one nutritive agent in distilled water to form a broth, incubating the broth at a predetermined temperature for a select period of time to induce probiotic activity; halting the probiotic activity, and separating the desired compound from the broth.. .
|Microencapsulated probiotic substance and process of manufacture|
Dried powder solid particles containing a probiotic microorganism and a carrier phase wherein said probiotic microorganism is encapsulated, said carrier phase further comprising at least a nutritious source, said dried powder solid particles present a particle size distribution between n and (n+400) pm, wherein n is comprised between 100 and 10000 μητl, preferably between 300 and 5000 pm, more preferably between 400 and 1000 pm.. .
|Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy|
This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth and/or activity of bifidobacteria using a prebiotic formulation which includes iso-malto oligosaccharides and β-glucanase. Other combinations of fibers and enzymes are described below which also stimulate growth and activity of lactobacilli or bifidobacteria.
|Nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms|
The present invention provides a nutritional composition that is suitable to reduce the impact of stress on intestinal symptoms and/or conditions. The composition comprises one or more selected from a probiotic microorganism,one or more inactive probiotic, and one or more culture medium of one or more probiotic; and soluble fiber, and possibly other ingredients such as a milk ingredient, a source of carbohydrates and a source of protein.
|Probiotics in a pre- and/or post-surgical environment|
The present invention relates generally to the field of nutrition, more particularly to the use of probiotics in nutrition. In particular the present invention relates to the use of a probiotic or of a mixture of probiotics in the manufacture of a nutritional composition or a medicament to act the colon in a pre- or post surgical environment..
|Dietary management of celiac disease and food allergy|
The present disclosure provides compositions and methods for dietary management of celiac disease and food allergy in a subject, such as a formula-fed infant, via enteral administration of an effective amount of at least one hydrolyzed protein and lactobacillus rhamnosus gg (lgg). The inventive nutritional compositions may contain a hydrolyzed protein component, a lipid component, a carbohydrate component, a vitamin component, a mineral component, and a prebiotic component in addition to a probiotic component, which comprises an effective amount of lgg..
|Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)|
The present invention relates to the general field of therapy of inflammatory bowel disease (ibd) and/or irritable bowel syndrome (ibs). Thus, the invention relates to a molecule selected from the trappin-2 protein or an active fraction thereof, a member of the wap family proteins or an active fraction thereof or a member of the serpin family proteins or an active fraction thereof for the treatment of irritable bowel syndrome (ibs).
|Use of a probiotic to regulate body weight|
The use of probiotic bacteria that modulate expression of a number of satiety markers in the intestine and reduces fat deposition to promote an optimal body weight of a mammal is described. The invention further relates to a composition comprising such a probiotic strain of bacteria and/or a fraction of said strain and/or metabolite of said strain for the preparation of a composition for administration to a mammal for promoting an optimal body weight of a mammal..
|Novel salmonella bacteriophage and uses thereof|
The present invention is directed to isolated bacteriophages having specificity and lytic activity against strains of salmonella species, methods of using the bacteriophages, progeny and derivatives derived therefrom, to control the growth of salmonella species in various settings (e.g., food safety, sanitation, probiotics).. .
|Synbiotic compositions for restoration and reconstitution of gut microbiota|
The present invention relates to synbiotic compositions comprising probiotic bacterial strains and prebiotic substances that, when combined exhibit synergistic behavior. The synergetic compositions will stimulate the indigenous microflora to restore and reconstitute in vivo gut like conditions after antibiotic associated diarrhea (aad), and/or other gut infections caused by gastrointestinal pathogens, and relapses thereof, as well as the prevention of said disorders..
|Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof|
A composition comprising probiotic bacteria, the composition comprising: (a) a core composition containing the probiotic bacteria and a stabilizer, wherein the total amount of probiotics in the mixture is from about 10% to about 90% by weight of the core composition; (b) an innermost coating layer, layered on said core composition, comprising at least one hydrophobic solid fat or fatty acid having a melting point lower than 60° c.; (c) an intermediate coating layer layered on said innermost coating layer, which when present in an aqueous solution in the amount of 0.1% weight/weight over the weight of the solution, has a surface tension lower than 60 mn/m, when measured at 25° c.; and (d) an outer coating layer, layered on said intermediate coating layer; wherein the composition is in the form of particles; food products containing the composition and methods of preparation thereof.. .
|Probiotics-containing soybean oligosaccharide product and preparation thereof|
Provided is a soybean oligosaccharide product containing acidic soluble saccharides of soybean and probiotics, which at least include fructose, glucose, sucrose, raffinose, and stachyose, with a percentage of the combined weight of raffinose and stachyose being at least 46%, a weight percentage of fructose being not greater than 8.5%, and a weight percentage of glucose being not greater than 1.0%, based on the total weight of fructose, glucose, sucrose, raffinose, and stachyose. The soybean oligosaccharide product is prepared by extracting a soybean raw material with water under a ph of 3-6 and at a temperature of 50-70° c.
|Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads|
Methods are provided for selecting a bacterium capable of reducing pathogenic bacterial colonization of the intestinal tract in a subject comprising selecting the bacterium capable of migrating at least 0.75 cm from the point of inoculation on motility agar after incubation for 24 hours at 37° c. Or capable of migrating from the point of inoculation to a diameter of at least 1.5 cm based on the farthest colonies from the point of inoculation on motility agar after incubation for 24 hours at 37° c.
This invention relates to a preparation comprising n-acetyl-lactosamine and/or an oligosaccharide containing n-acetyl-lactosamine and a probiotic lactobacillus sp. The invention extends to nutritional compositions comprising said preparation and to the use of the preparation in the prevention and treatment of pathogenic infections of the gastro-intestinal and upper respiratory tracts..
|Tumour cytotoxic agent and methods thereof|
The present invention discloses a novel antitumour agent which provides an antitumour activity based on metabolites with reduced side effects. Moreover, the antitumour agent is prepared starting with a highly safe bacterium used in food production, which is a probiotic lactic acid bacterium..
|Prebiotic formulations and methods of use|
The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
|Use of probiotic organisms synthesizing carotenoid compounds to enhance human health and nutrition|
A method is disclosed for increasing systemic carotenoid levels in humans through oral consumption of tablets, capsules, food or beverage products containing organisms capable of synthesizing carotenoid compounds. Carotenoid synthesis may occur in situ by organisms colonizing the gut, or in food or beverage products where carotenoids accumulate and are subsequently consumed dietarily.
|Pet food preparations containing probiotic micro-organisms|
The present invention relates to the field of pet food. In particular, the present invention provides pet food compositions comprising non-replicating probiotic micro-organisms.
|Composition for preventing inflammations|
The purpose of the present invention is to provide a probiotic(s) which can activate an aromatic hydrocarbon receptor (ahr) and can consequently prevent inflammatory damage in the digestive tract. The present invention relates to; a probiotic(s) capable of activating an ahr; an anti-inflammatory agent comprising the probiotic(s); an orally ingestible composition containing the anti-inflammatory agent; and a method for screening for the probiotic(s)..
|Novel probiotic bacillus sp. strain|
The present invention relates to a novel bacillus sp. Strain having probiotic activity.
|Treatment and prevention of eczema|
The present invention broadly relates to the use of probiotics for the treatment and prevention of dermatitis. More particularly, the present invention relates to the use of a composition comprising lactobacillus acidophilus strain i-1492 deposited at the cncm, a lactobacillus casei lbc80r® strain and a carrier for treating or preventing hand dermatitis..
|Composition comprising a sensitive ingredient|
A composition having from 45% to 90%, by weight, of a first portion and from 10% to 55%, by weight, a second portion. The first portion has a lower melting point than the second portion.
|Probiotics in fruit beverages|
The present invention relates to a method of producing a probiotic fruit beverage comprising a high viable count of acid-adapted probiotic bacteria, such as strains of lactobacillus paracasei subsp. Paracasei, and to probiotic fruit beverage obtainable by such method..
|Probiotic composition for livestock, and method for preparing same|
The present invention relates to an eco-friendly probiotic composition, and more particularly, to a probiotic composition for livestock production, comprising a lactic acid bacteria culture medium and an organic acid, wherein the organic acid is contained in an amount of 0.002 to 0.1 parts by weight relative to 1 parts by weight of the lactic acid bacteria culture medium. The present invention also relates to a method for preparing the composition.
|Probiotics and methods of obtaining same|
This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.. .
|Dry food product containing live probiotic|
The disclosure relates to a probiotic delivery system that can be consumed as a snack-food or added to a food product. In particular, the disclosure describes a crisp and tasty treat that comprises viable probiotic microorganisms preserved in a vacuum dried matrix of sugars, proteins, and polysaccharides.
|Spoonable yogurt preparations containing non-replicating probiotic micro-organisms|
The present invention relates to the field of spoonable yogurt compositions. In particular, the present invention provides spoonable yogurt compositions comprising non-replicating probiotic micro-organisms.
|Vaccine compositions and uses thereof|
The present invention relates to vaccine compositions and uses thereof. Embodiments of the present invention provide oral bacterial (e.g., probiotic lactic acid bacteria) vaccine delivery systems comprising an antigen and a dendritic cell-targeting peptide.